Navigation Links
ITN's TrialShare wins National Academies Board on Research Data and Information challenge
Date:7/17/2014

Seattle, WA (July 16, 2014) The Immune Tolerance Network's (ITN) TrialShare Clinical Trials Research Portal has won the National Academy of Sciences Data and Information Challenge. The theme of this year's competition, launched and judged by the academy's Board on Research Data and Information (BDRI), was "Using Data for the Public Good."

The ITN's entry, entitled "ITN TrialShare: Enabling True Clinical Trial Transparency" describes the unique data sharing portal developed by the NIH-sponsored clinical research consortium. The system provides clinical trial investigators an unprecedented ability to share data with other researchers. Among its unique features are the ability to access raw de-identified participant level study data, review published analysis methods, and perform real-time interactive graphical analyses in collaboration with other researchers.

The BRDI Data and Information Challenge was created by the National Academy of Sciences as a means of increasing awareness of current issues surrounding the collection and use of scientific research data, including accessibility, integration, and reproducibility; as well as promoting new opportunities for novel analyses, allowing for maximum societal benefit from the available data.

With a number of high profile drug failures in the past decade, there is a growing movement within government, industry, and academia for greater transparency in the reporting of clinical trial results. Substantial progress has been made in reaching consensus on the need for change; however a number of technical and procedural challenges have limited the ability to implement effective solutions. ITN TrialShare has been created to specifically address many of these issues.

"Modern clinical trial data is highly complex, often including information related to genetic testing and other high throughput techniques that generate a lot of data," says Adam Asare, ITN Director of Bioinformatics. "What we've done is create a set of intuitive tools that allow researchers to share and analyze their data in multiple ways you can be an expert statistician or a novice, and find what you need."

Anyone with a valid email address can self-create a free ITN TrialShare account in minutes and start accessing hundreds of datasets for dozens of completed studies, data and analyses. ITN TrialShare currently has data and specimen bio-repository information associated with 35 trials and 3,200 participants available to the public in the therapeutic areas of transplant, allergy, autoimmunity, and type I diabetes. ITN makes the underlying data from all published and closed studies, regardless of outcome, available through TrialShare. ITN TrialShare was built and customized using the LabKey Server open source framework.


'/>"/>

Contact: Philip Bernstein
ITNCommunications@immunetolerance.org
240-235-6132
Immune Tolerance Network
Source:Eurekalert

Related biology news :

1. Researchers at LSTM crack the genetic secret of mosquito resistance to DDT and ITNs
2. National Xenopus resource at the MBL innovates new way to study proteins
3. Registration is now open for the HFES 2014 International Annual Meeting
4. Largest International Meeting for the Study of Reproductive Biology Attracts Researchers from 36 Countries in Grand Rapids, Michigan
5. International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019
6. National Electronic ID Programs Generate $54 Billion Between 2013 and 2018 with 3.5 Billion National eID Card Holders Worldwide
7. Marshall University to partner with international company in drug development venture
8. UC Riverside plant pathologist receives national recognition
9. Highlights for 2014 national meeting of worlds largest scientific society
10. The ICIST-KAIST International Conference 2014 from August 4-8, 2014 in Korea
11. International Tree Nut Council study results may help people with type 2 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, 2017, ... the Genome hackathon at Microsoft,s headquarters in ... competition will focus on developing health and wellness apps ... Hack the Genome is the first hackathon ... The world,s largest companies in the genomics, tech and ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):
(Date:6/28/2017)... (PRWEB) , ... June 28, 2017 , ... ... and assisting small businesses in their marketing efforts, announced that their new website ... in its design, but key on the site is the offering of no-cost ...
(Date:6/28/2017)... , June 28, 2017 Spectrecology LLC ... boost their STEM education and research dollars. The program ... the latest fiber optic spectroscopy and photonics equipment despite ... are: Innovations in ... 10% of equipment purchases used for the classroom or ...
(Date:6/28/2017)... ... 28, 2017 , ... Alevio, LLC ( http://www.aleviospine.com ), a ... using the SiCure Sacroiliac Joint Fusion System. , SiCure is a second-generation comprehensive ... implanted in either a lateral or posterior approach, and is indicated for skeletally ...
(Date:6/28/2017)... ... June 28, 2017 , ... ... UK Ltd (Bock) announced a strategic partnership where Bock will demonstrate DuPont’s ... OPTIMASH® AD-100, has been shown to help biogas producers in the agricultural sector ...
Breaking Biology Technology: